DnB Markets - Lundin Energy AB (LUNE) All eyes on Korpfjell

Report

DnB Markets

All eyes on Korpfjell

Lundin Petroleum (LUPE SS, Buy) - All eyes on Korpfjell
(14 pages)

27/07/2017 14 EN

Underlying

Lundin Energy AB

Lundin Petroleum is an oil and gas company. Co. has a global portfolio of assets with two main areas located in Norway and South East Asia. As of Dec 31 2014, Co. held close to 70 licences in Norway, with activities across exploration, appraisal, development and production. Co. also operated within several geographical areas, including France, Netherlands, Malaysia, Indonesia, Russia, Sweden and other countries.

See profile

SE0000825820 Nasdaq Nordic Stockholm Sweden

Provider

DnB Markets

DNB Markets is the investment banking arm of DNB Bank ASA and is focused primarily on the Nordic region, as well as internationally on niches such as global shipping, energy and related services, and seafood. DNB Markets offers services in FICC, Equities and Investment Banking advisory from offices in Oslo, Stockholm, London, Singapore and New York. Equity research coverage is offered on c250 Nordic companies. DNB was ranked no.2 in Extel Nordic Research 2017. The DNB Markets’ Credit and FICC Macro & FX Research teams are repeatedly highly rated by Prospera Nordic Institutional Investor Surveys.

See profile

Other Reports on these Companies

GlobeNewsWire

Orrön Energy publishes it’s Annual and Sustainability Report for 2023

Orrön Energy publishes it’s Annual and Sustainability Report for 2023 Orrön Energy AB (“Orrön Energy”) is pleased to announce the publication of it’s Annual and Sustainability Report for 2023 and encourages shareholders to read or download the report on Orrön Energy’s website, For shareholders who would like to receive a printed copy of the Annual and Sustainability Report 2023, this can be requested on Orrön Energy’s website or by telephone on . For further information, please contact: Robert ErikssonDirector Corporate Affairs and Investor RelationsTel: 5 Jenny Sandström Communicat...

April 17, 2024 April 17, 2024 1 EN

GlobeNewsWire

Orrön Energy publicerar sin års- och hållbarhetsrapport för 2023

Orrön Energy publicerar sin års- och hållbarhetsrapport för 2023 Orrön Energy AB (“Orrön Energy”) publicerar sin års- och hållbarhetsrapport för 2023 och uppmuntrar aktieägare att läsa eller ladda ner rapporten på Orrön Energys hemsida Aktieägare som önskar få ett tryckt exemplar av års- och hållbarhetsrapporten för 2023, kan efterfråga detta via Orrön Energys hemsida eller via telefon på 08-440 54 50. För mer information, vänligen kontakta: Robert ErikssonDirector Corporate Affairs and Investor RelationsTel: 5 Jenny Sandström Communications LeadTel: 8 Denna information är sådan ...

April 17, 2024 April 17, 2024 1 EN

GlobeNewsWire

Orrön Energy sells its 50 percent interest in the Leikanger hydropower plant in Norway for MEUR 53

Orrön Energy sells its 50 percent interest in the Leikanger hydropower plant in Norway for MEUR 53 Orrön Energy AB (“Orrön Energy” or “the Company”) is pleased to announce that it has entered into an agreement to sell its 50 percent interest in the Leikanger hydropower plant for an enterprise value of MNOK 613, approximately MEUR 53, to the existing partner Sognekraft Produksjon AS (“Sognekraft”). This transaction forms part of the Company’s strategy of having an opportunistic approach to value creation, and to take advantage of favourable market conditions as they arise. The sale of the L...

April 12, 2024 April 12, 2024 1 EN

Medistim (Hold, TP: NOK190.00) - Sales in Americas weaken

Revenues grew 3.5% YOY in Q1 (currency-neutral total sales grew 2.2%), below our estimate c6%. The EBIT margin of 24% was almost back to normal and in our view shows the low margin in Q4 2023 (16.4%) should be seen as a one-off. However, we remain concerned about revenue growth, especially in the Americas, after the fifth consecutive quarter of declining currency-neutral sales. Thus, while we reiterate our HOLD, we have lowered our 2024–2026e sales by c3–8% and cut our target price to NOK190 (210).

Free Trial

7h / 30m 7h / 30m 1 EN

Niklas Wetterling

Niklas Wetterling

Catena (Buy, TP: SEK515.00) - Time to put the money to work

The Q1 results were solid in our view; although the vacancy rate rose, it was from a very low level, and was therefore of limited concern. We reiterate our BUY and have raised our target price to SEK515 (500). In our view, Catena has (too much) firepower following its last equity raise and we would like to see more M&A, project activity, or speedy reinvestment. Following the equity raise the stock looks highly valued on a 2025–2026e P/FFO of 21–19x, but that drops to 15–14x adjusted for earnings from our forecast recurring development gains.

Free Trial

7h / 30m 7h / 30m 1 EN

Miika Ihamaki

Miika Ihamaki

Kesko (Hold, TP: EUR17.00) - Technical(ly) weak

Q1 disappointed due to Building & Technical Trade (BTT) profitability well below expectations. We continue to see a mixed case, with stable to gradually improving Grocery Trade (GT) but still-weak Building & Technical Trade. We reiterate our HOLD but have cut our target price to EUR17 (18), after lowering our 2024–2026e clean EBIT and DPS by c4%.

Free Trial

7h / 30m 7h / 30m 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

All eyes on Korpfjell

Orrön Energy publishes it’s Annual and Sustainability Report for 2023

Orrön Energy publicerar sin års- och hållbarhetsrapport för 2023

Orrön Energy sells its 50 percent interest in the Leikanger hydropower plant in Norway for MEUR 53

Medistim (Hold, TP: NOK190.00) - Sales in Americas weaken

Catena (Buy, TP: SEK515.00) - Time to put the money to work

Kesko (Hold, TP: EUR17.00) - Technical(ly) weak

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe